undamentalytics Newsletter
Sign in

Health In Tech, Inc. income statement

In fiscal 2025, Health In Tech, Inc. reported revenue of $33.3m, up 71.0% on the year before and net income of $1.3m, or $0.02 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue19193333
Cost of revenue241215
Gross profit17152118
Research and development2322
Selling and marketing3346
General and administrative881414
Interest expense00——
Provision for credit losses—01—
Income before tax312−5
Income tax100−1
Net income211−4
Diluted EPS—$0.01$0.02−$0.07
Diluted shares (average)—54m58m60m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HIT vs XHGHIT vs RDZNEZRA vs HIT

More: Insurance Brokers stocks compared, Financials sector, rankings of US companies

Figures from Health In Tech, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Health In Tech, Inc.